Welcome to our dedicated page for Procter & Gamble SEC filings (Ticker: PG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Procter & Gamble Company (PG) files a wide range of documents with the U.S. Securities and Exchange Commission, providing detailed insight into its operations, capital structure, governance, and shareholder policies. As a New York Stock Exchange‑listed issuer with common stock and multiple series of notes registered under Section 12(b) of the Exchange Act, P&G uses SEC filings to report material events, financing activities, executive and director matters, and shareholder meeting results.
Recent Form 8‑K filings illustrate the types of information investors can find. Regulation FD 8‑Ks document quarterly dividend declarations on common stock and ESOP convertible preferred stock, along with the company’s long record of consecutive dividend payments and increases. Other 8‑Ks report underwritten public offerings of U.S. dollar, euro, and pound sterling notes with various maturities, including floating rate notes and fixed‑rate notes issued under a shelf registration statement on Form S‑3, with related legal opinions filed as exhibits.
Additional 8‑Ks address governance topics such as the approval of The Procter & Gamble 2025 Stock and Incentive Compensation Plan, voting results from the Annual Meeting of Shareholders, and retirement announcements for senior executives. Earnings‑related 8‑Ks furnish quarterly results, slides used on earnings calls, and notices of webcasts. Together with the company’s proxy statement on Schedule 14A, these filings give a structured view of P&G’s executive compensation framework, board composition, and strategic priorities.
On this page, Stock Titan provides real‑time access to Procter & Gamble’s SEC filings as they appear on EDGAR, along with AI‑powered summaries to help explain the significance of each document. Users can quickly review annual and quarterly reports, current reports on Form 8‑K, and exhibits related to new debt offerings or compensation plans, as well as monitor items such as dividend announcements and shareholder vote outcomes without reading every page of the underlying filings.
The Procter & Gamble Company priced a primary offering of €1,000,000,000 senior euro notes in two tranches: €500,000,000 of 2.900% notes due November 3, 2033 and €500,000,000 of 3.650% notes due November 3, 2045. Interest accrues from November 3, 2025 and is payable annually in arrears, with the first payment on November 3, 2026.
The pricing table shows initial offering prices of 99.761% (2033) and 99.916% (2045), underwriting discounts of 0.338% and 0.500%, and aggregate proceeds to the issuer before expenses of €994,195,000. The notes are optionally redeemable at a make‑whole amount based on the applicable Comparable Government Bond Rate plus 10 bps. Application will be made to list the notes on the NYSE, subject to approval. The notes will clear through Clearstream and Euroclear and will be issued in €100,000 denominations (and €1,000 multiples thereafter).
The Procter & Gamble Company: a stockholder filed a Form 144 for a proposed sale of 725 shares of common stock with an aggregate market value of $110,123.88. The approximate sale date is October 30, 2025, to be executed on the NYSE through Morgan Stanley Smith Barney LLC.
The filer reported acquiring 1,044 shares on August 18, 2025 via a Performance Stock Program Award. In the past three months, the filer reported a sale of 319 shares on August 19, 2025 for $50,170.34 in gross proceeds.
Shares outstanding were 2,336,733,549; this is a baseline figure, not the amount being offered.
The Procter & Gamble Company launched a preliminary prospectus supplement for a primary offering of Floating Rate Notes due 2075. The notes pay interest quarterly at a rate equal to Compounded SOFR minus 0.45%, with a 0.00% floor, beginning on February 4, 2026, and mature on November 4, 2075. The company may redeem the notes, in whole or in part, starting November 4, 2055 at step-down prices listed in the supplement, plus accrued interest. Holders have put rights beginning November 4, 2026, annually through 2036 at stated prices and every third year thereafter at 100% of principal, each plus accrued interest. If a tax event occurs, P&G may shorten maturity so interest remains deductible for U.S. federal income tax purposes. The notes will not be listed on any exchange and are expected to settle via DTC; Morgan Stanley is named in the supplement.
For context, for the quarter ended September 30, 2025, net sales were $22,386 million, operating income was $5,856 million, and net earnings attributable to P&G were $4,750 million. Diluted EPS was $1.95 on diluted weighted average shares of 2,436.8 million.
Procter & Gamble (PG) filed a preliminary prospectus supplement for a two‑tranche senior notes offering. The company plans to issue two series of notes with semiannual interest payments beginning in 2026, accruing from 2025. The notes may be redeemed at P&G’s option at a make‑whole price based on a Treasury Rate formula. The notes will be delivered through DTC, Clearstream and Euroclear and will not be listed on any exchange. Proceeds, before expenses, are payable to the company.
Underwriters include Citigroup, Goldman Sachs and Morgan Stanley. As context, for the quarter ended September 30, 2025, net sales were
The Procter & Gamble Company launched a preliminary prospectus supplement for a primary offering of euro‑denominated senior notes in two series. Interest will be paid annually in arrears starting in 2026, and the notes may be redeemed at P&G’s option at make‑whole prices, plus a tax redemption if certain U.S. tax events occur. The notes will be issued in registered form in minimum denominations of €100,000 and integral multiples of €1,000. Application will be made to list the notes on the New York Stock Exchange.
The offering will settle in book‑entry form through Clearstream and Euroclear. The supplement includes standard “additional amounts” provisions for non‑U.S. holders to address withholding, and outlines product governance and retail investor restrictions in the EEA and UK. P&G highlights macroeconomic, geopolitical, supply chain, cybersecurity and regulatory risks relevant to its global operations.
As context, for the quarter ended September 30, 2025, net sales were $22,386 million and net earnings attributable to P&G were $4,750 million, with diluted EPS of $1.95. As of September 30, 2025, total assets were $127,599 million, long‑term debt was $24,315 million and shareholders’ equity was $53,551 million.
The Procter & Gamble Company reported first‑quarter results for the three months ended September 30, 2025. Net sales were $22.4 billion, up 3% year over year, driven by 1% pricing, 1% mix and 1% favorable foreign exchange. Operating income was $5.9 billion (up 1%), while gross margin was 51.4% (down 70 bps) and operating margin was 26.2% (down 50 bps).
Net earnings rose 20% to $4.8 billion, and diluted EPS increased 21% to $1.95, reflecting the prior year’s Argentina-related charges. Operating cash flow was $5.4 billion; capital expenditures were $1.2 billion; adjusted free cash flow was $4.9 billion with 102% productivity. The company paid $2.55 billion in dividends and repurchased $1.25 billion of stock.
By segment, net sales grew in Beauty (+6%), Grooming (+5%), Health Care (+2%), Fabric & Home Care (+1%) and Baby, Feminine & Family Care (+1%). P&G incurred $215 million in restructuring charges as part of its two‑year $1.5–$2.0 billion productivity plan. The Glad joint venture will not be renewed; P&G expects about $500 million of proceeds and a $250–$300 million after‑tax gain in the third quarter of fiscal 2026. Shares outstanding were 2,336,733,549 as of September 30, 2025.
The Procter & Gamble Company furnished a Regulation FD update tied to its first-quarter results. On October 24, 2025, the company announced those results, hosted a conference call, and made a slide presentation available to investors. The materials are furnished under Item 7.01.
PG attached Exhibit 99.1, titled “Informational Slides Provided by The Procter & Gamble Company,” and included the Inline XBRL cover page file as Exhibit 104. The slides referenced on the call are also posted on the company’s website.
The Procter & Gamble Company furnished a Form 8-K under Item 2.02 to note it issued a news release regarding earnings for the quarter ended September 30, 2025.
The company attached the news release as Exhibit 99.1. The filing is presented as an informational update about recent operating results and financial condition.
The Procter & Gamble Company reported that shareholders approved the 2025 Stock and Incentive Compensation Plan, which authorizes awards covering up to 175,000,000 shares of common stock. The plan permits grants of stock, RSUs, PSUs, options, and SARs, and also allows use of any shares remaining available under the 2019 plan.
At the October 14, 2025 Annual Meeting, all director nominees were elected. Shareholders ratified the independent auditor, and the advisory Say on Pay vote was approved. A shareholder proposal requesting additional reporting on plastic packaging did not pass.
Procter & Gamble (PG) reported an insider transaction: Director Patricia A. Woertz acquired 31 shares of common stock on 10/14/2025 at $0, coded as an “A” transaction.
The filing notes these were Restricted Stock Units awarded under The Procter & Gamble 2019 Stock and Incentive Compensation Plan. Following the transaction, Woertz beneficially owns 51,548.5268 shares, held directly.
FAQ
What is the current stock price of Procter & Gamble (PG)?
What is the market cap of Procter & Gamble (PG)?
